Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sharon N Edmiston

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Cancer Research|April 4, 2002
Prevalence and spectrum of p53 mutations associated with smoking in breast cancerKathleen Conway, Sharon N Edmiston, Lisa Cui, et al.
The Journal of Investigative Dermatology|January 1, 2010
Relationship between germline MC1R variants and BRAF-mutant melanoma in a North Carolina population-based studyNancy E Thomas, Peter A Kanetsky, Sharon N Edmiston, et al.
Breast Cancer Research : BCR|October 8, 2014
DNA methylation profiling in the Carolina Breast Cancer Study defines cancer subclasses differing in clinicopathologic characteristics and survivalKathleen Conway, Sharon N Edmiston, Ryan May, et al.
Carcinogenesis|December 8, 2005
IGF1 CA repeat polymorphisms, lifestyle factors and breast cancer risk in the Long Island Breast Cancer Study ProjectRebecca J Cleveland, Marilie D Gammon, Sharon N Edmiston, et al.
Pigment Cell & Melanoma Research|March 8, 2011
DNA-methylation profiling distinguishes malignant melanomas from benign neviKathleen Conway, Sharon N Edmiston, Zakaria S Khondker, et al.
The Journal of Investigative Dermatology|November 29, 2021
Characterization of the CpG Island Hypermethylated Phenotype Subclass in Primary MelanomasKathleen Conway, Yihsuan S Tsai, Sharon N Edmiston, et al.
Pigment Cell & Melanoma Research|July 3, 2014
DNA methylation profiles in primary cutaneous melanomas are associated with clinically significant pathologic featuresNancy E Thomas, Nathaniel A Slater, Sharon N Edmiston, et al.
JCO Precision Oncology|March 17, 2023
Pathway Alterations in Stage II/III Primary MelanomaCaroline E Kostrzewa, Li Luo, Arshi Arora, et al.
Biorxiv : the Preprint Server for Biology|November 18, 2024
Improving Accuracy of Somatic Mutation Profiling in Large Epidemiologic Studies: Addressing Cases without Matched Normal SamplesArshi Arora, Li Luo, Caroline E Kostrzewa, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 18, 2007
Number of nevi and early-life ambient UV exposure are associated with BRAF-mutant melanomaNancy E Thomas, Sharon N Edmiston, Audrey Alexander, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Cancer Research|April 4, 2002
Prevalence and spectrum of p53 mutations associated with smoking in breast cancerKathleen Conway, Sharon N Edmiston, Lisa Cui, et al.
The Journal of Investigative Dermatology|January 1, 2010
Relationship between germline MC1R variants and BRAF-mutant melanoma in a North Carolina population-based studyNancy E Thomas, Peter A Kanetsky, Sharon N Edmiston, et al.
Breast Cancer Research : BCR|October 8, 2014
DNA methylation profiling in the Carolina Breast Cancer Study defines cancer subclasses differing in clinicopathologic characteristics and survivalKathleen Conway, Sharon N Edmiston, Ryan May, et al.
Carcinogenesis|December 8, 2005
IGF1 CA repeat polymorphisms, lifestyle factors and breast cancer risk in the Long Island Breast Cancer Study ProjectRebecca J Cleveland, Marilie D Gammon, Sharon N Edmiston, et al.
Pigment Cell & Melanoma Research|March 8, 2011
DNA-methylation profiling distinguishes malignant melanomas from benign neviKathleen Conway, Sharon N Edmiston, Zakaria S Khondker, et al.
The Journal of Investigative Dermatology|November 29, 2021
Characterization of the CpG Island Hypermethylated Phenotype Subclass in Primary MelanomasKathleen Conway, Yihsuan S Tsai, Sharon N Edmiston, et al.
Pigment Cell & Melanoma Research|July 3, 2014
DNA methylation profiles in primary cutaneous melanomas are associated with clinically significant pathologic featuresNancy E Thomas, Nathaniel A Slater, Sharon N Edmiston, et al.
JCO Precision Oncology|March 17, 2023
Pathway Alterations in Stage II/III Primary MelanomaCaroline E Kostrzewa, Li Luo, Arshi Arora, et al.
Biorxiv : the Preprint Server for Biology|November 18, 2024
Improving Accuracy of Somatic Mutation Profiling in Large Epidemiologic Studies: Addressing Cases without Matched Normal SamplesArshi Arora, Li Luo, Caroline E Kostrzewa, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 18, 2007
Number of nevi and early-life ambient UV exposure are associated with BRAF-mutant melanomaNancy E Thomas, Sharon N Edmiston, Audrey Alexander, et al.
Pageof 4